Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins
Cell Host & Microbe · 2026
DOI: 10.1016/j.chom.2026.04.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2026. Verfasst von Marissa Acciani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Measles virus, Viral Fusion Proteins, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Measles virus (MeV), a highly transmissible paramyxovirus, can cause severe complications and death, particularly in infants and young children. How and where human antibodies target and neutralize MeV remain unclear. Here, we report a panel of human monoclonal antibodies (mAbs) specific for MeV hemagglutinin (H) and fusion (F) surface proteins, derived from the memory B cells of a Measles-Mumps-Rubella (MMR) vaccinee. We mapped four and five major epitope clusters on H and F, respectively, and structurally characterized representative mAbs from each epitope cluster. MAbs against both H and F offer broad, potent, picomolar-level neutralization and substantially reduce viral loads in vivo when delivered before or after viral exposure. High-resolution cryo-electron microscopy of mAb complexes with H and F reveal highly conserved contact sites of the most protective antibodies. Characterization of these fully human mAbs provides avenues for prophylactic or therapeutic intervention against re-emerging MeV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
- Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
- Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
- Department of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
- Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
- Swiss National Science Foundation
- National Institute of Allergy and Infectious Diseases
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
Zitieren
APA
Acciani, M., Zyla, D., Niemeyer, G., Harkins, S., Parekh, D., Pawlack, E., Lacarbonara, D., Kansara, D., Ackerman, M. E., Niewiesk, S., Porotto, M., Hastie, K. M., & Saphire, E. O. (2026). Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins. Cell Host & Microbe. https://doi.org/10.1016/j.chom.2026.04.010
Vancouver
Acciani M, Zyla D, Niemeyer G, Harkins S, Parekh D, Pawlack E, et al. Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins. Cell Host & Microbe. 2026. doi:10.1016/j.chom.2026.04.010
BibTeX
@article{Acciani2026,
author = {Acciani, Marissa and Zyla, Dawid and Niemeyer, Gele and Harkins, Stephanie and Parekh, Diptiben and Pawlack, Emily and Lacarbonara, Davide and Kansara, Dhvanir and Ackerman, Margaret E and Niewiesk, Stefan and Porotto, Matteo and Hastie, Kathryn M and Saphire, Erica Ollmann},
title = {Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins},
journal = {Cell Host & Microbe},
year = {2026},
doi = {10.1016/j.chom.2026.04.010}
}
EUVIMED